What are particle accelerators and how do they help create new products?

We are used to thinking of particle accelerators as pure research instruments. There are however over 30'000 of them in the world and they are widely used by different industries, from med-tech and computer industry to food and security industries. Accelerator and related technologies are in the origin of many innovations.

A digital copy of the world

Nomoko AG is developing the platform that will contribute to the creation of an entirely new market for products built on real-world-based 3D data. The core of the platform is built on Nomoko’s technology that will enable them to create accurate, ultra-realistic 3D models of the cities we live in – also called the “digital twin of the world”.

Drug Discovery Made in Switzerland

Drug discovery has come a long way from guess work to a structural and targeted approach to finding new and better remedies. To develop new drugs, companies need to stay up to date about the latest discoveries in genomics, proteomics, structural or quantitative biology.

Robotics: Innovation and R&D in Switzerland

Forbes recently called Switzerland “the Silicon Valley of Robotics” and said the country has “emerged as a serious competitor to California for the technologies, people and funding that will power the world’s fourth socio-economic revolution”. Find out why.


At least two Swiss teams hold solar world records: ­Solar ­Impulse and AtlantikSolar. In 2016, Solar Impulse completed the first ever around-the-world flight in a purely solar-powered airplane. EPFL and Empa were key partners. AtlantikSolar, developed at ETH Zurich, holds the world record for the longest fully solar-powered flight ever (81 hours) of an unmanned aerial vehicle (UAV).


This breakthrough technology for deep-seated tumor irradiation has become one of the ­leading forms of tumor and cancer treatment around the world. With proton therapy, tumor tissues are destroyed using protons.


In 2016, the first ever Olympic-style competition for disabled ­people using robotics-based assistive technologies took place in Zurich: Cybathlon.

Virtual Reality Specto VR

Medical Application of Virtual and Augmented Reality Tools. With the Virtual Reality tool SpectoVR, doctors can interact in a three-dimensional space with the patient data prior to surgery.


evolaris aviation gmbh – a spin-off of the Bern University of Applied science – has developed an electrical high power aerobatic motor for the swiss aerobatic aircraft VOTEC 221 in the past 2 years.

The MIRACLE Project

MIRACLE, short for Minimally Invasive Robot-Assisted Computer-guided LaserosteotomE, aims to develop a robotic endoscope to perform contact-free bone surgery with laser light.

Electron Diffraction for Drug Discovery

Modern pharmaceutical development is tailored to the chemical and physical characteristics of active organic compounds. Obtaining a polymorph portfolio of a compound is a demanding process. With its advantages, electron diffraction represents one of the most promising fields of research for unlocking new possibilities in structure-based drug discovery.

A new method for cheaper solar-energy storage

Storing solar energy as hydrogen is a promising way for developing comprehensive renewable energy systems. Building on a unique idea, EPFL scientists have now developed a simple, unconventional method to fabricate high-quality, efficient solar panels for direct solar hydrogen production with low cost.

Unprecedented level of detection

The results of the research and development activities in chemical, pharmaceutical and many other areas often depend on the correctly identified structure of the analyzed sample. X-Ray Powder Diffraction (XRPD) is considered the gold standard method for identifying and quantifying crystalline solid forms and provides the industry with crucial data.

Disabled people pilot a robot remotely with their thoughts

Using a telepresence system developed at EPFL, 19 people – including nine quadriplegics – were able to remotely control a robot located in one of the university laboratories. This multi-year research project aims to give a measure of independence to paralyzed people. Each of the 9 subjects with disabilities managed to remotely control the robot with ease.

Innovative Cancer Immunotherapy

IPS Biopharma is a biotech company developing a proprietary drug for use in the innovative cancer immunotherapy inCVAX for the treatment of solid metastatic tumors.

Who we are

The Swiss Innovation Park «Switzerland Innovation» gives easy access to talent, knowledge and expertise. It is the ideal place for technology-driven companies to create their next breakthrough or best- selling product.


Dr. Matthias Leuenberger

Delegate Novartis Switzerland

Switzerland has a strong commitment to ­intellectual property and a great research ­environment with excellent universities.

Roger von Mentlen

Member of the Executive Committee of UBS Switzerland

Switzerland is a small country – but not when it comes to innovation and financial services. These two important drivers of Switzerland's economic success depend on a business environment that enables international competitiveness and a strong innovation ecosystem with companies of all shapes and sizes. Innovation through collaboration is key for Switzerland and for UBS.

Kaspar E. A. Wenger

Chairman of the Board of Directors of Holcim (Schweiz) AG

The two decisive factors for Switzerland as an innovation location are the liberal and stable economic system and the excellent infrastructure. This results in a very high quality of life, which makes Switzerland attractive for international companies and leading specialists. Furthermore, our educational institutions represent a culture of quality and progress.

Patrick Warnking

Country Director Google Switzerland

Quality in terms of training, research and innovation is a key factor behind the success of our investments in Switzerland – alongside local partnerships with players from academia, business, politics and society in the field of ­digital education and beyond. It provides a solid foundation that has seen Google Switzerland become the company’s largest R&D site outside the USA.

Monika Rühl

Chairwoman of the Executive Board at economiesuisse

The success of Switzerland as a center for production and thinking depends essentially on the quality of the collaboration between universities and the private sector. The innovation parks fill an important gap in this respect. They combine different research competencies in one location, create synergies and strengthen the innovative power of the Swiss economy.

Dr. René Cotting

Head of Operations, Innovation and R&D ABB Group

Knowledge and innovation are the key to the success of Switzerland – and ABB. But we can only remain successful if we continue to invest in top talents and R&D, if we are able to develop new, innovative products for our customers, and if we can successfully market these products. That is why we need Switzerland Innovation.

Andreas Gerber

Head of SME Business Switzerland, Credit Suisse (Schweiz) AG

Switzerland is a globally interconnected platform with sophisticated skills, legal certainty and access to customized financing opportunities for international companies. For the future it is key to show effective economic policy and regulation, and to invest in new technologies and education to remain unique and internationally competitive.

Eric Rolland

PhD, Head of Nestlé Institute of Health Science

At the innovation park, through our cooperation with academia, we have easy access to people, expertise, knowledge and state-of-the-art research. We are in close proximity to ­exciting start-ups and technology companies and are able to attract ­excellent graduate students and researchers.

Roger Wüthrich-Hasenböhler

Chief Digital Officer of Swisscom

Switzerland offers an excellent ecosystem for fostering innovation. The key pillars are the high level of education, significant investments in research and the strong infrastructure. But the open mindset and cooperation between companies provide the needed boost for innovation to thrive.

André Hoffmann

Vice Chairman of the Board of Directors of F. Hoffmann-La Roche Ltd

Innovation is the result of creative, intelligent people; however, even the best people cannot be innovative enough without the right environment. Switzerland offers excellent conditions for everyone looking to innovate: a stable, democratic system with legal certainty, respect for intellectual property, and an excellent education system.

Dr. Patrick Frost

CEO Swiss Life

As a small and networked country, Switzerland offers companies the benefit of short distances: universities collaborate closely with companies using a practice-based approach, and politicians acknowledge the needs of business. These attributes form the ideal basis for rapid innovation and ongoing renewal.

Jean-Daniel Pasche

President of the Federation of the Swiss Watch Industry FH

The excellent reputation of Swiss watchmaking is proof that Switzerland offers the ideal conditions to develop projects in this field – both now and in future. Many foreign watchmaking companies have established locations in our country to take advantage of the high level of training, the political stability and the reliability of our infrastructure.

Theresa Visarius

VP IPS Biopharma AG

The Switzerland Innovation Park Biel/Bienne provides an ideal environment for startups by offering an infrastructure and network so important to young companies. Their highly skilled staff take a personal interest and promote swiss innovation as they strive to meet the individual needs of each company.

Martin Keller

CEO Sika Switzerland

Sika's success and reputation is based on its long-established tradition of innovation. Sika files about 70 new patent applications every year and therefore Sika’s patent portfolio is constantly growing. At present it comprises more than 700 unique patent families, more than 2’700 single patents. Sika’s research activities are carried out at its 20 technology centres worldwide, with Switzerland as a key location. About a third of our 900 R&D staff worldwide is based in Switzerland, a country famous for its liberal economic order and its first-class educational system.

Innovations Areas

Research Expertise You Will Find at the Switzerland Innovation Parks

Health and Life Sciences

Drug discovery and design, precision/personalized medicine, medtech, biotech, diagnostics, biomedical engineering, nutrition, human physiology


Computer and Computational Science

Data security (for example blockchain), data analytics, artificial intelligence, storage ­technologies, the Internet of Things (IoT), smart sensors, cloud computing, bioinformatics


Energy, Natural Resources and Environment

Energy storage, smart grids, power generation, smart building / living, energy/resource efficiency, green chemistry, alternative energy sources


Mobility and Transportation

Aviation and space, autonomous driving, avionics and drones, electric mobility and batteries, traffic planning and transport systems, mobility infrastructure


Manufacturing and Materials

Robotics, automation, industry 4.0, advanced manufacturing, ­accel­erator technology, ­nondestructive testing, new ­materials, nanotechnology, ­microelectronics


Your Research Partners

Switzerland Innovation Gives You Access to World-Leading Research Institutions

R&D Centers in Switzerland


Excellent conditions

What are your benefits as a technology-driven company?

Academic Excellence

Collaborate with world-class academic partners. Easy access to the best talents and researchers


Find exciting high-tech start-ups and spin-offs

Industry Partners

Exchange ideas and forge partnerships with R&D teams from top international companies

Innovation Services

Industrial liaison officers to help your R&D staff to maximize their opportunities


Approximately 200,000 square ­meters of high-end laboratories, ­offices, ­conference rooms and ­coworking spaces. Large, accelerator-based research facilities.

stable ­environment

Business-friendly and politically stable ­environment

development area

More than 40 hectares of development area

research funding

Access to Swiss and EU research funding

Quality of Life

Very high quality of life, attractive for top talents and their families